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13C glucose labelling studies using 2D NMR
are a useful tool for determining ex vivo
whole organ metabolism during
hypothermic machine perfusion of kidneys
Jay Nath1,2* , Tom Smith2, Alex Hollis2, Sam Ebbs2, Sefa W. Canbilen2, Daniel A. Tennant2, Andrew R. Ready1
and Christian Ludwig2
Abstract
Background: The aim of this study is to determine the feasibility of using nuclear magnetic resonance (NMR) tracer
studies (13C-enriched glucose) to detect ex vivo de novo metabolism in the perfusion fluid and cortical tissue of
porcine kidneys during hypothermic machine perfusion (HMP).
Methods: Porcine kidneys (n = 6) were subjected to 24 h of HMP using the Organ Recovery Systems LifePort
Kidney perfusion device. Glucose, uniformly enriched with the stable isotope 13C ([U-13C] glucose), was incorporated
into KPS-1-like perfusion fluid at a concentration of 10 mM. Analysis of perfusate was performed using both 1D 1H
and 2D 1H,13C heteronuclear single quantum coherence (HSQC) NMR spectroscopy. The metabolic activity was then
studied by quantifying the proportion of key metabolites containing 13C in both perfusate and tissue samples.
Results: There was significant enrichment of 13C in a number of central metabolites present in both the perfusate
and tissue extracts and was most pronounced for lactate and alanine. The total amount of enriched lactate (per
sample) in perfusion fluid increased during HMP (31.1 ± 12.2 nmol at 6 h vs 93.4 ± 25.6 nmol at 24 h p < 0.01). The
total amount of enriched alanine increased in a similar fashion (1.73 ± 0.89 nmol at 6 h vs 6.80 ± 2.56 nmol at 24 h
p < 0.05). In addition, small amounts of enriched acetate and glutamic acid were evident in some samples.
Conclusions: This study conclusively demonstrates that de novo metabolism occurs during HMP and highlights
active metabolic pathways in this hypothermic, hypoxic environment. Whilst the majority of the 13C-enriched
glucose is metabolised into glycolytic endpoint metabolites such as lactate, the presence of non-glycolytic pathway
derivatives suggests that metabolism during HMP is more complex than previously thought. Isotopic labelled ex
vivo organ perfusion studies using 2D NMR are feasible and informative.
Keywords: Hypothermic machine perfusion, Kidney, Transplantation, Metabolism, NMR, Isotopic tracer study, 13C
Background
Although there is good evidence to support the use of
hypothermic machine perfusion (HMP) in clinical practice
[1–3], there are surprisingly few reports detailing renal
metabolism during this process. This is likely to reflect the
widely held belief that metabolism is deleterious during
organ preservation and should be therefore minimised by
both hypothermia and keeping cold ischaemia times (CIT)
as short as possible. The concept that metabolic support
may have beneficial effects during HMP in addition to the
mechanical effects is relatively recent [4, 5].
Using a one-dimensional (1D) 1H nuclear magnetic res-
onance (NMR) metabolomic approach, we have previously
identified a panel of metabolites within the perfusion fluid
during HMP that are predictive of post-transplant graft
function [6]. We have also demonstrated that porcine and
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human metabolic profiles are similar, validating the pig as a
valid metabolic model for kidney transplant studies [7].
However, the metabolic ‘snapshot’ provided by this
conventional NMR metabolomic approach has limitations
for the understanding of cellular metabolism in complex
models such as ex vivo organ perfusion. Merely identifying
and quantifying a metabolite is often insufficient in the
determination of any reliable mechanistic information:
even with serial measurements, such relationships are
often unclear. For example, the detection of lactate within
the perfusate of a machine-perfused kidney could be
secondary to the metabolism or release of pre-existing
intracellular substrate stores as well as de novo metabol-
ism of substrates derived from the perfusion fluid. Thus,
the appearance of a particular metabolite within the perfu-
sion fluid does not confirm de novo metabolism. For this
reason, we propose performing isotopic 13C-labelled
glucose studies.
Incorporation of stable isotopes such as 13C into
common compounds enables metabolic tracer studies
within a biological system. This is not a new concept,
with initial studies reported over 40 years ago [8].
Introduction of labelled metabolic precursors can high-
light specific pathways within the metabolic network.
For example, after addition of [U-13C] glucose to the
fluid of a kidney during HMP, detection of uniformly
labelled 13C lactate provides unequivocal evidence of
glycolytic pathway activity.
NMR spectroscopy is a powerful tool to analyse com-
plex 13C isotopomer/isotopologue distributions in me-
tabolites derived from labelled tracer molecules. There
are various spectroscopic methods available, of which
the simplest is a 1D 13C approach. 1D NMR organ
perfusion studies have been reported in ex vivo heart
and lung animal models using perfusate labelled with
13C glucose and pyruvate [9–12]. This demonstrates the
feasibility of using 13C-labelled metabolic precursors to
determine de novo metabolism in a whole organ perfu-
sion model. 2D 1H,13C HSQC NMR is an alternative to
1D 13C NMR, benefitting from higher sensitivity and in-
creased spectral dispersion. Whilst previous authors
have demonstrated the utility of a human 2D NMR ap-
proach using 13C-labelled glucose [13], to our knowledge
there are no reports of this technique in the field of
transplantation.
The aim of this study is to assess whether metabolic
pathway activity within a machine-perfused porcine kid-
ney can be determined using 13C-labelled glucose tracer
experiments and 2D NMR.
Methods
Pig studies
Experiments were performed on 22–26-week-old ‘bacon
weight’ pigs, weighing 80–85 kg (n = 6) as described
elsewhere [7]. All experiments were performed following
the principles of laboratory animal care according to NIH
standards. To replicate human conditions, kidneys were
initially cold flushed (4 °C) with 1 l Soltran solution under
aseptic conditions at a pressure of 150 mmHg, followed by
2 h of cold storage. Organs were then perfused with 1 l of a
modified version of KPS-1 solution containing 10 mM of
[U-13C]-labelled glucose and 30 g of PEG 35 kDa as an
impermeant in place of hydroxyethyl starch. The LifePort
Kidney Transporter 1.0 (Organ Recovery Systems) was
used for perfusion at a pressure of 30 mmHg (Fig. 1).
Kidneys were perfused for 24 h with perfusate sampled
at times 6, 12, 18 and 24 h from each kidney via the
designated LifePort sampling port and stored at −20 °C.
The samples were thawed at room temperature, pre-
pared and processed as described below. Kidney cortex
tissue samples were also taken at the study endpoint and
flash frozen prior to homogenization.
2D NMR spectroscopy
2D HSQC NMR experiments were performed in this study.
This type of 2D NMR exploits the spin properties of both
protons (1H) and isotopic carbon (13C) such that only 13C
nuclei with an attached 1H produce a signal on the result-
ing spectrum (Fig. 2). Whilst the pulse sequence used here
actively decouples 1H and 13C, inter-proton and inter-
carbon couplings are still active. However, the only coup-
ling resolved in the resulting NMR spectra is the 13C–13C
coupling. Thus the spectral peak of a 13C nuclei is altered if
there is an adjacent 13C nuclei, in that the signal is split
and two peaks exist, splitting into four if flanked by a 13C
either side (Fig. 3). In these experiments, [U-13C] glucose
was used as a tracer (i.e. 13C nuclei in all six carbon posi-
tions of the glucose molecule) therefore forming lactate
Fig. 1 LifePort Kidney Transporter 1.0 (Organ Recovery Systems)
containing a porcine kidney. a Bubble chamber. b Reservoir for ice.
c Aortic patch connector for perfusion. d Peristaltic pump. e
Controls (pressure, prime, wash, infuse). f Sampling port
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with all three carbons in the isotopic 13C version produced
through glycolysis. As the natural abundance of 13C is
known (1.1 %) and the likelihood of adjacent 13C nuclei
occurring naturally very low (1.1 %2 = 0.0121 %), it is pos-
sible to determine the relative concentration of isotopic
carbon molecules compared to the natural abundance
levels by performing quantum-mechanical simulations of
the different components of an experimental HSQC multi-
plet (Fig. 3). Absolute concentrations of metabolites can be
determined using 1D 1H NMR, and therefore, absolute
concentrations of labelled metabolites can be calculated
using a combination of these two NMR approaches.
Sample preparation
Perfusates
Perfusate samples were extracted using a chloroform/
methanol extraction. Briefly, 1.5 ml of perfusate was com-
bined with 1.5 ml of chilled methanol (at −80 °C) and
1.5 ml chloroform (i.e. a 1:1:1 ratio). This was mixed vig-
orously for 10 min and then cooled on wet ice for 10 min.
The polar and non-polar phases were separated by centri-
fugation (1300g for 15 min at 4 °C) as described elsewhere
[14, 15] and 2 ml of the polar fraction aspirated and dried
at 30 °C overnight. The dried samples were resuspended
in 480 μl NMR phosphate buffer containing 0.1 M phos-
phate buffer (pH 7.0), 0.5 μM DSS (4,4-dimethyl-4-sila-
pentane-1-sulfonic acid), 2 mM imidazole, and 48 μl D20
(deuterium oxide), and vortexed until the dried pellet had
completely dissolved. Following this, 35 μl of the sample
was added to a 1.7-mm NMR tube, sonicated for 10 min
to dissolve any remaining micro particles and then centri-
fuged to remove air bubbles. The sample was stored at 4 °
C until processed.
Tissues
Immediately after storage, the kidneys were laterally
bisected and sections of cortex were excised and snap
frozen in liquid nitrogen. Sections of cortex were then
pulverised to a fine powder using a manual cryogrinder.
After this, 0.5 g of the powdered sample was added to a
7-ml Precellys homogenisation tube containing 5.1 ml
of chilled methanol (−80 °C) to quench ongoing metab-
olism. The sample was homogenised using the Precellys
24 Dual homogeniser set at the lowest mode (5000 rpm
for 15 s) until fully homogenised (this was standardised
to eight courses of the lowest setting with cooling in
dry ice between runs to prevent overheating). Once
homogenised, the samples were mixed with 4.65 ml
ultrapure water accounting for the estimated 79 %
water (around 395 μl) present in the tissue already [16]
and 5.1 ml chloroform (i.e. a 1:1:1 ratio as with the
perfusate samples).
Metabolite extraction and resuspension in NMR buffer
was performed as in the perfusate sample preparation,
with the exception that 4.5 ml of the top polar layer was
Fig. 2 A 2D HSQC spectrum of extracted pig kidney cortex is shown in a. A 3D plot of the methyl group (carbon 3) signal of lactate is displayed
in b. c A cross section through the middle of the methyl group signal. The recorded spectrum is plotted in black, whereas a quantum-
mechanical simulation of the same multiplet is shown in red. The plot demonstrates that the simulation allows for a fully quantitative analysis of
the NMR multiplets, which forms the base for a subsequent isotopomer/isotopologue analysis
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aspirated and dried before resuspension in 60 μl of
NMR phosphate buffer and 35μl of this was added to a
1.7mm NMR tube as before.
NMR spectroscopy
Both 1D 1H NMR and 2D 1H,13C HSQC NMR spectra
were acquired on a 600-MHz Bruker Avance III NMR
spectrometer equipped with a TCI 1.7-mm z-PFG cryo-
genic probe at 300 K. NMR acquisition time was circa
5 h per sample (Fig. 4). The spectral widths for all spec-
tra were set to either 7812.5 Hz (1H) or 24,155 Hz (13C).
For the 1D 1H NMR spectra, 16,384 complex data points
were acquired. For the 1H dimension of 2D 1H,13C
HSQC NMR spectra, 512 complex data points were
acquired. Out of 8192 complex data points (2458), 30 %
were sampled for the 13C dimension using an exponen-
tially weighted non-uniform sampling scheme. Using a
4-s interscan relaxation delay, 128 transients were
recorded for the 1D NMR spectra. Two transients per
increment were recorded for the 2D 1H,13C HSQC
NMR spectra. The interscan relaxation delay was set to
1.5 s. Each sample was automatically tuned, matched
and then shimmed (1D TopShim) to a DSS line width of
<1 Hz prior to acquisition of the first spectrum. 1D 1H
NMR spectra were processed using the MATLAB-based
MetaboLab software [17]. All 1D data sets were zero-
filled to 131,072 data points prior to Fourier transform-
ation. The chemical shift was calibrated by referencing
the DSS signal to 0 ppm. 1D spectra were manually
phase corrected before correcting the spectral baseline
using a spline function [17]. 1D 1H NMR spectra were
then exported into Bruker format for metabolite identifi-
cation and concentration determination using Chenomx
8.1 (ChenomxINC). 2D 1H,13C HSQC NMR spectra
were reconstructed with compressed sensing using the
MDDNMR and NMRpipe software [18–20]. The spectra
Fig. 3 Possible multiplet components for the central carbon (carbon 2) of lactate. Clockwise (a–d), the four possible multiplet components are
shown. The spectrum shown in a contains 13C in position 2 only, whereas positions 1 and 3 carry a 12C nucleus. In both b and c, one of the
adjacent carbon nuclei carries an additional 13C nucleus in the same molecule. Therefore, the NMR signal is split into two resonance lines
(doublet). Because of the different chemistry of carbons 1 and 3, the amount of splitting depends on which neighbour carries the 13C nucleus.
This is why splittings can be used to uniquely assign which neighbouring carbon is labelled even though it may be impossible to directly
observe that carbon, such as carbon 1, in a HSQC spectrum. The multiplet for a fully labelled lactate molecule is plotted in d. Because both
neighbouring carbons are 13C, the signal is now split into four peaks (doublet of doublets). Under normal circumstances, multiplets will contain a
mixture of those patterns. Such a mixture is shown in e. Despite the rather complex appearance of this signal, it can be fully quantified by a
quantum-mechanical signal deconvolution
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were zero-filled to 1024 (1H) times 16,384 (13C) real data
points. HSQC spectra were then analysed using Metabo-
Lab, which uses the pyGamma software for multiplet
simulations [21]. The methyl group of lactate was used
to calibrate the chemical shift based on its assignment in
the human metabolome database [22].
Statistical analysis
Data were analysed using GraphPad Prism v6 (GraphPad
Software, San Diego, USA). Data were reported as mean
± SD, unless stated otherwise. Statistical significance was
tested using two-tailed Student’s t test. A p value of
<0.05 was considered significant.
Results
An understanding of the active metabolic pathways dur-
ing HMP could potentially facilitate the development of
a more nutritionally supportive perfusion fluid enabling
the metabolic optimisation of these valuable organs prior
to transplantation.
In this donation after cardiac death (DCD) large ani-
mal model of kidney transplant preservation, enrichment
of 13C in a number of metabolites was observed in both
perfusate solution and kidney cortex tissue. This con-
firms that de novo metabolism occurs during HMP and
that the proposed NMR methodology is useful to dem-
onstrate this. Even after 6 h of perfusion, glycolytic activ-
ity was evident with enriched [U-13C] lactate, enriched
[U-13C] alanine and enriched [U-13C] acetate detected in
the perfusion fluid.
The proportion of [U-13C] enriched lactate (as a frac-
tion of the total lactate present) increased over the
study period (3.25 % ± 1.02 after 6 h and 7.74 % ± 1.57
after 24 h p < 0.001). In addition, the total concentra-
tion of lactate present (enriched and non-enriched) in-
creased (1.51 ± 0.20 mM at 6 h and 2.04 ± 0.57 mM at
24 h p < 0.05). Given that the total amount of enriched
lactate present at a given time point is the product of
the relative proportion (e.g. 3.25 %) and total concen-
tration (e.g. 1.51 mM), it is self-evident that as both of
these are increasing; the amount of enriched lactate
being produced is also increasing (total amount of la-
belled [U-13C] lactate (per sample) 31.1 ± 12.2 nmol at
6 h vs 93.4 ± 25.6 nmol at 24 h p < 0.01).
There is a similar pattern observed with alanine with
the enriched proportion increasing (1.25 % ± 0.44 at 6 h
and 2.83 % ± 1.19 at 24 h p < 0.05) and the total concen-
tration increasing by a similar proportion (0.24 mM ±
0.018 at 6 h and 0.41 mM± 0.13 at 24 h p < 0.01) (total
[U-13C] alanine per sample (1.73 ± 0.89 nmol at 6 h vs
6.80 ± 2.56 nmol at 24 h p < 0.05)) (Fig. 5).
Whilst enriched acetate was present at all time
points in the perfusion fluid (circa 1.25 %), there was
no change in concentration over time. Similarly, the
total concentration of acetate did not change over
time, suggesting that either the production of acetate
was limited or being converted to other enriched
substrates.
The same enriched metabolites (lactate, alanine and
acetate) were also present in the extracted kidney cortex
samples at all time points. In addition, glutamate with
13C enrichment in the 4 and 5 carbon position was
present in several samples in small amounts (<0.5 % of
total present). The presence of this labelling pattern in
glutamate indicates mitochondrial tricarboxylic acid
(TCA) cycle activity (via pyruvate dehydrogenase and
complex 1).
Discussion
This paper provides further evidence that a significant
amount of metabolism occurs during HMP and that
NMR methods are useful for identifying these [6, 7, 23].
However, unlike 1H NMR reports, this paper provides
unequivocal evidence that de novo metabolism occurs in
these organs during HMP with the glucose present in
the perfusate used as a substrate. To our knowledge this
is the first report to demonstrate such de novo metabol-
ism in a whole organ ex vivo kidney model using NMR
tracer methods.
The labelled tracer study techniques described herein
highlight active metabolic pathways during the machine
perfusion period. This could be particularly useful as
clinicians seek to alter perfusion characteristics in order
to optimise kidney graft function prior to transplant.
Fig. 4 Schematic representation of 2D HSQC NMR spectrum.
Chemical shift for 1H depicted on the x-axis and 13C on the y-axis.
Whilst in both the projected 1D 1H and the 1D 13C spectrum display
signal overlap, all signals are well resolved in the 2D spectrum
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The metabolic effects of such perfusion modification
(e.g. temperature, oxygenation, oxygen carriers) can be
elegantly demonstrated using 13C NMR, with analysis of
perfusion fluid permitting non-invasive metabolic
monitoring.
The appearance of uniformly labelled lactate and ala-
nine in the perfusate and tissue samples demonstrate
that de novo glycolysis is occurring in this non-
physiological environment and that alternative meta-
bolic pathways such as the pentose phosphate pathway
do not appear to be active. Although cellular metabol-
ism is reported to only be about 5–8 % at temperatures
below 4 °C [24] with similar oxygen requirements [25],
hypothermia does not cause uniform deceleration of all
metabolic pathways [4] and the metabolic effects of
hypothermia within different organs is not uniform
[26]. There is some evidence that the energy substrate
utilised to support metabolism in a hypothermic canine
ex vivo model is predominantly glucose entering
glycolysis [27], highlighting the importance of this
pathway during machine preservation of organs. Inter-
estingly, other studies demonstrate an increase in per-
fusate metabolites such as glutamate during perfusion.
The suggested mechanism was the reduction (and de-
amination) of glutamine to glutamate by glutaminase.
The authors concluded that the deamination of glutam-
ate occurs to form alpha-ketoglutarate, an important
TCA cycle intermediate [28].
The presence of labelled acetate within the perfusate is
interesting. Whilst acetate can be formed from multiple
pathways, the early appearance of the labelled substrate
in these experiments may indicate acetyl-coA hydrolase
activity [29].
The labelled metabolites in this study were detectable
in the extracellular perfusion fluid within 6 h and dem-
onstrates that cellular uptake of glucose, glycolysis and
transport/efflux of resulting metabolites occurs within
this time period. Although the proportion of de novo
metabolites is modest, it does occur independently of
any glucose uptake stimulators such as insulin.
There has been great interest in the role of oxygen-
ation and oxygen carriers during kidney preservation,
with proponents suggesting that oxygenation replenishes
cellular ATP levels [30] and detractors highlighting the
perils of uncontrolled oxygenation exacerbating the
reactive oxygen species (ROS) generation [31] and the
ischaemia reperfusion phenomenon [32]. This study
demonstrates that even in the absence of supplemental
oxygen, small amounts of glucose-derived glutamic acid
were observed in several tissue samples indicative of aer-
obic TCA cycle activity. Although this is surprising, it
must be remembered that HMP is not an anoxic envir-
onment and oxygen solubility increases at lower temper-
atures and increased salinity and the preservation
solution is further saturated by the physical fluid agita-
tion that occurs during perfusate cycling. Whilst other
Fig. 5 Changes over time for lactate and alanine in the perfusion fluid of HMP kidneys. a, b The % enrichment present and c, d the total
concentration of these metabolites. In all cases, there was a significant increase both in 13C enrichment and in concentrations between
the 6- and 24-h samples
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metabolites indicative of TCA activity were commonly
identified using NMR such as citrate, succinate and
fumarate (by 2D and/or 1D), they were not labelled to
indicate de novo formation.
One of the benefits of the 2D NMR methodology used
in this paper is that the sensitivity (per unit time) is in-
creased compared with 1D 13C NMR. However, 13C
NMR is inherently less sensitive than 1H NMR, and
therefore, it is possible that labelled metabolites present
in very small quantities would not be identified using
this method. Furthermore, our 2D database of splitting
patterns and chemical shift parameters for different
metabolites is evolving and other labelled metabolites
may be identified once these have been further clarified.
Whilst we feel the 2D NMR methods in this paper relay
unparalleled amounts of metabolic information, they are
both time consuming and resource intensive and would
not be suitable for real-time analysis to inform clinical
decisions, as proposed for 1D 1H NMR studies [23].
The experimental conditions in these experiments
were standardised as much as possible to reduce inter-
experimental variability and designed to replicate clinical
conditions. Whilst previous studies have repeatedly
demonstrated the viability of porcine kidneys after simi-
lar periods of HMP [23, 33], this study does not seek to
corroborate this and as such we are unable to correlate
de novo metabolism with functional outcome. Given the
findings from earlier studies [6], we hypothesise that
glycolytic activity during perfusion may correlate with
post-transplant function and propose a human observa-
tional study to clarify this, which is possible due to the
non-radioactive nature of the 13C isotope used in this
study.
Conclusions
We conclude that the described 13C labelling study con-
vincingly demonstrates de novo metabolism during kid-
ney storage by HMP, and this can be used to highlight
active metabolic pathways in this hypothermic, hypoxic
environment.
We postulate that although most of the supplied 13C-
enriched glucose is converted to endpoint metabolites
associated with glycolytic metabolism (i.e. lactate), the
presence of labelled non-glycolytic pathway derivatives
suggests that kidney metabolism during HMP storage is
more complex than previously thought.
Isotopic labelled ex vivo organ perfusion studies using
2D NMR are therefore informative and feasible. Meta-
bolic manipulation is a potential target for therapeutic
intervention during the preservation period, and accur-
ate understanding of active metabolic pathways could
potentially facilitate studies to optimise this, potentially
improving the function of the kidneys post-transplant.
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